FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/13/2026
Back to search
Official data from USPTO
HAEMA BLUT UND PLASMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
08/13/2026
Trademark type
Combined
Nice classes
5, 35, 42, 44
Filing date
07/04/2024
Registration date
01/20/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/20/2026
Last transaction
08/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
27
Owner location
DE
Examiner
ABID, NABEELA
Law office
O50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "HAEMA BLUT UND PLASMA" in red with a design of a red oval and red curved band.
Holders and representatives
Holders
Haema GmbH
Haema AG
Representatives
Deborah L. Shapiro Moses & Singer LLP
Technical classification
Nice Classes
Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinesin particular medicines made from blood componentsfractions and preparationswith said medicines being for the treatment of diseases and disorders of the blood; blood componentsfractions and preparationsblood for medical purposesblood plasmablood substitutes for human use; blood componentsfractions and preparations for injectionblood for medical purposesblood plasmablood substitutes for human use; blood componentsfractions and preparations for automatic transplantationblood for medical purposesblood plasmablood substitutes for human use; blood componentsfractions and preparations for transfusionblood for medical purposesblood plasmablood substitutes for human use; blood componentsfractions and preparations for immunotherapyblood for medical purposesblood plasmablood substitutes for human use; blood componentsfractions and preparations for autologous transfusionblood for medical purposesblood plasmablood substitutes for human use; bloodblood fractions and blood components for medicaltherapeutic and prophylactic purposesblood for medical purposesblood plasmablood substitutes for human use; blood plasma; cells for medical useblood cell preparations; health care substances and preparationsin particular for haematologypharmaceuticals for the treatment of blood diseases and disordersblood for medical purposesblood plasmablood substitutes for human use; finished medical productsblood for human use and blood plasma; preparations for medical purposesin particular haematology preparationspharmaceuticals for the treatment of blood diseases and disordersblood for medical purposesblood plasmablood substitutes for human use; immunotherapeutic and immunoprophylactic preparationspharmaceuticals for treating immunological diseases and disorders; living cells for medical purposesleukocyte preparations of white blood cells; Living cells and cell fragments for medical purposesplatelet and red blood cell concentrates; blood plasmaquarantine plasma and fractionated plasma; clinical medical reagents for processing human blood and blood components for use in blood transfusions and for extracorporeal blood processing stored in bagsbottlessyringes and similar containers for storing substances such as these for medical purposes; pharmaceutical products and haematology preparations for the treatment of blood and blood componentsin particular infusion and transfusion solutions in the nature of bloodblood plasmablood substitutes for human use and pharmaceuticals for the treatment of blood diseases and disorders; pharmaceutical blood plasma preparations for the treatment of blood diseases and disorders; pharmaceutical blood preparations for the treatment of blood diseases and disorders; pharmaceutical blood productspharmaceuticals for the treatment of blood diseases and disorders; cell material for autotransplantation and autotransfusioncells for medical use; cell material for transplantation and transfusioncells for medical use; cell material for medicaltherapeutic and prophylactic purposescells for medical or clinical use
Class 35
Updating and maintenance of blood donor data in computer databases
Class 42
Technical provision and support for data processing systemsproviding technology information in the field of data processing and technical support services in the nature of troubleshooting computer software problems in connection with data processing; providing temporary use of online non-downloadable computer software for accessing patient treatment databases and donor databases; providing technological and scientific information about scientific laboratories services and blood banksin particular medical laboratories; providing scientific information derived from analysis of medical diagnostic results; blood analysis services for scientific research purposes; scientific laboratory services; chemical laboratories and medical research laboratories; scientific research in the field of physics; chemistry serviceschemical analysischemical laboratories; chemical analysis; scientific testing servicesblood testing for scientific research purposes; blood testing for scientific research purposeswith said testing entailing filtrationseparation and centrifugation of blood; laboratory trialsmedical and scientific research in the nature of conducting clinical trials for others; development and further development of data processing computer software and hardware in the field of laboratory medicine and blood and plasma collection; database development servicescreation of medical databases in digital form; scientific and medical research in the medical and pharmaceutical fields; scientific and medical research in the field of chemistry and biology; development and establishment of testing specifications and procedures for the medical industrydevelopment of medical equipment procedures and test proceduresdonation procedures and medical instrument procedures
Class 44
Medical analysis services and medical consultancy all relating to the treatment of persons in connection with blood and plasma donation; medical consultancy in relation to transfusion medicine; pharmacy advice in the nature of pharmaceutical advice; providing of medical information in relation to blood donation centres; providing of medical and pharmaceutical support being medical assistance and pharmaceutical advice via telephone; medical services in the field of blood fractionation and treatment; medical services in the field of blood sampling and collection; blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; blood bank services; blood donation centres being health center services; blood extraction stations being health center services; medical services in the field of immunotherapy; medical consultancy in relation to transfusion medicine and clinic hygiene; medical transfusion consultancy in clinicsin particular medical consultancy by doctors administering transfusions; medical transfusion testing for diagnostic or treatment purposes; providing medical diagnostic information through medical results; medical diagnostic services within the framework of conducting medical examinations; conducting of blood donationplatelet donationerythrocyte donationwhole blood donationplasma donationautologous donationall in the nature of blood bank services; medical examination services; execution of clinical examination servicesmedical examination services; dietetic advisory services; medical services in the nature of providing medical opinions; health counselling; medical services in the field of transfusion and transplantation of blood and blood components; medical services; providing medical information relating to the use of medical equipmentinstruments and apparatus for medical purposes; medical services relating to packed red blood cell banks; medical services relating to platelet concentrate banks; medical services relating to leukocyte banks; medical services relating to blood plasma banksblood for medical and diagnostic purposes; blood component banks being blood bank services; health assessment servicesproviding a database in the field of blood donor medical information based on collected data and information all for treatment and diagnostic purposes; extraction of stem cells being medical services relating to the removaltreatment and processing of stem cells
Publications
History of USPTO decisions and trademark events.
33 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/27/2026
FIMP
FINAL DISPOSITION PROCESSED
07/27/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/28/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/11/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/11/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/20/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/20/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/20/2026
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/02/2025
PUBO
PUBLISHED FOR OPPOSITION
12/02/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/26/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/25/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/31/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
10/31/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/31/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
10/31/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/31/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2025
RFNT
REFUSAL PROCESSED BY IB
09/27/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/05/2025
RFRR
REFUSAL PROCESSED BY MPU
09/05/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/01/2025
CNRT
NON-FINAL ACTION WRITTEN
07/31/2025
DOCK
ASSIGNED TO EXAMINER
07/31/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/30/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/30/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/18/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2024
Continuous trademark protection
Get notified about every new filing that threatens HAEMA BLUT UND PLASMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.